| No`. of patients (n) | Overall incidence No. (%) | No. of patients using standard treatment (n) | Specific incidence of SWI after standard treatment No. (%) | No. of patients using NPWT (n) | Specific incidence after NPWT No. (%) | P value |
---|---|---|---|---|---|---|---|
Atkins et al. [5] | 57 | 0 (0%) | NA | NA | 57 | 0 (0%) | NA |
Colli et al. [17] | 10 | 0 (0%) | N/A | N/A | 10 | 0 (0%) | NA |
Grauhan et al. [13] | 150 | 15 (10%) | 75 | 12 (16%) | 75 | 3 (4%) | P = 0.0266 |
Grauhan et al. [18] | 3745 | 122 (3.3%) | 3508 | 119 (3.4%) | 237 | 3 (1.3%) | P < 0.05 |
Witt-Majchrzak et al. [19] | 80 | 13 (16.2%) | 40 | 3 (7.5%) | 40 | 10 (25%) | P = 0.03 |
Santarpino et al. [20] | 129 | 6 (4.7%) | 108 | 6 (5.6%) | 21 | 0 (0%) | P = 0.336 |
Reddy [21] | 27 | 4 (14.8%) | N/A | N/A | 27 | 4 (14.8%) | NA |
Philip et al. [22] | 10 | 0 (0%) | NA | NA | 10 | 0 (0%) | NA |
Gatti et al. [7] | 53 | 8 (15.1%) | NA | NA | 53 | 8 (15.1%) | NA |
Ruggieri et al. [9] | 256 | 27 (10.5%) | 128 | 14 (10.9%) | 128 | 13 (10.2%) | P = 0.819 |
Suleo-Calanao et al. [23] | 1859 | 122 (6.6%) | 927 | 81 (8.7%) | 932 | 41 (4.4%) | P = 0.0005 |
Tabley et al. [24] | 233 | 25 (10.7%) | 91 | 16 (17.6%) | 142 | 9 (6.3%) | P = 0.009 |
Rashed et al. [25] | 98 | 6 (6.3%) | 52 | 6 (11.1%) | 46 | 0 (0%) | P = 0.026 |
Brega et al. [26] | 90 | 13 | 60 | 12 | 30 | 1 | P = 0.06 |
Nguyen et al. [27] | 1199 | 4.3% | 493 | 31 (6.3%) | 706 | 21 (3%) | P = 0.01 |